Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the
progression to tractional retinal detachment following intravitreal anti-VEGF therapy in an …

Tractional retinal detachment is an end-stage form of diabetic retinopathy that occurs when
contractile forces in the vitreous and neovascular tissue lead to the detachment of the …

Proliferative diabetic retinopathy (PDR) is a common cause of blindness in the developed
world's working adult population and affects those with type 1 and type 2 diabetes. We …

Over the past four decades, advancements in surgical instrumentations and techniques
have significantly improved the postoperative anatomical and visual outcomes of patients …

Purpose To investigate the clinical manifestations and surgical results after vitrectomy for
proliferative diabetic retinopathy (PDR) in young patients. Methods Clinical features of …

Abstract Background Association of Alzheimer's Disease (AD) with Type 2 Diabetes (T2D)
has been well established. Cyclo (His-Pro) plus zinc (Cyclo-Z) treatment ameliorated …

Objectives: Identify the risk factors and epidemiology of retinal detachment. Determine the
pathophysiology, clinical features, differential diagnoses, prognosis, and complications of …

Pars plana vitrectomy (PPV) is the main treatment modality for patients with severe diabetic
retinopathy. With the development of systems for microincision, wide-angle viewing, digitally …

Background To report our experience using 27-gauge pars plana vitrectomy (PPV) system
for treating patients with combined tractional and rhegmatogenous retinal detachments …

Purpose To test the efficacy of runt-related transcription factor 1 (RUNX1) inhibition with
topical nanoemulsion containing Ro5-3335 (eNano-Ro5) in experimental ocular …